Insights

Top brokers name 3 ASX shares to sell next week

Brokers aren’t feeling overly positive on these shares…
The post Top brokers name 3 ASX shares to sell next week appeared first on The Motley Fool Australia. –

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that caught my eye are summarised below. Here’s why top brokers think investors ought to sell these shares next week:

A2 Milk Company Ltd (ASX: A2M)

According to a note out of Credit Suisse, its analysts have retained their underperform rating and $5.50 price target on this infant formula company’s shares. Although the broker notes that infant formula prices were stable in August and channel inventory is heading in the right direction, it isn’t enough for a change of rating. The broker continues to be concerned with its market position and China’s slowing birth rate. Credit Suisse fears its weak Stage 1 formula sales could impact future Stage 2 and Stage 3 sales. The A2 Milk share price ended the week at $5.51.

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

A note out of Citi reveals that its analysts have retained their sell rating and NZ$27.00 (A$26.11) price target on this medical device company’s shares. Citi notes that lower COVID-related hospitalisations in Europe and North America are weighing on demand for its products in FY 2022. This has led to a decline in sales financial year to date. In light of this, the broker appears to believe its shares are overvalued at the current level. The Fisher & Paykel Healthcare share price was fetching $31.62 at Friday’s close.

Macquarie Group Ltd (ASX: MQG)

Another note out of Citi reveals that its analysts have retained their sell rating and lifted their price target on this investment bank’s shares to $153.00. The broker notes that Macquarie is guiding to a better than expected first half performance in FY 2022. However, this isn’t enough for a change of rating. Particularly given the broker’s belief that the second half will be tougher. As a result, the broker continues to believe that Macquarie’s shares are expensive at the current level and retains its sell rating. The Macquarie share price ended the week at $174.23.

The post Top brokers name 3 ASX shares to sell next week appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

September is not being kind to the BHP (ASX:BHP) share price
How have ASX healthcare shares performed during the August 2021 earnings season?

How does the A2 Milk (ASX:A2M) share price compare to the ASX 200 today?
Top brokers name 3 ASX shares to sell today

The Macquarie (ASX:MQG) share price has gained 3 times that of CBA over 5 years

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!